Abstract
A randomized phase II study using mitomycin (MMC)/cisplatin (DDP) regimen with or without Kanglaite (KLT, a traditional Chinese medicine) as salvage treatment was conducted to exploit KLT's potential effects on patients with advanced breast cancer (ABC). Triweekly regimen consisted of mitomycin (8 mg/m(2)) administered intravenously on day 1, and cisplatin (25 mg/m(2)) intravenously on days 1 to 3. KLT (100 ml) was given intravenously per day on days 1 to 14 every 3 weeks. Between April 2006 and July 2007, 60 patients with a median age of 48 years were randomized into MMC/DDP with or without KLT treatment. In all, the objective response rate (ORR) was 17.5%. There were no significant differences between experimental and control treatments in terms of ORR (14.3% vs. 20.7%, p = 0.730), clinical benefit rates (24.1% vs. 28.6%, p = 0.468), median time to progression (TTP; 3.63 vs. 4.0, p = 0.872), and overall survival (OS; 7.17 vs. not reached, p = 0.120). The median TTP for patients with complete or partial responses was 6.0 months, but only 2.1 months for patients with stable or progressive disease (SD or PD; p = 0.028). While the median OS for patients who obtained clinical benefit from chemotherapy was not reached, that of pati...Continue Reading
References
Jan 1, 1990·Cancer Chemotherapy and Pharmacology·D R GandaraR W Carlson
Dec 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G W SledgeL H Einhorn
Jan 1, 1981·Cancer·A B MillerA Winkler
Oct 1, 1993·Journal of Surgical Oncology·Y SaikawaM Kitajima
Apr 1, 1993·Oncology·G N Hortobagyi
Mar 27, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D MavroudisV Georgoulias
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J M NabholtzM Aapro
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M H CullenR L Souhami
Mar 10, 2001·Cancer Treatment Reviews·W T Bradner
Aug 31, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H C WagenaarJ B Vermorken
Dec 18, 2001·Cancer·J L BlumB Osterwalder
May 2, 2003·Seminars in Oncology·Andrew D Seidman
Jul 26, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P ReichardtH J Lück
Sep 10, 2003·Anti-cancer Drugs·Peter C Thuss-PatiencePeter Reichardt
Sep 16, 2003·Cancer·Pierre FumoleauPeter Reichardt
Oct 10, 2003·Cancer Investigation·M VassilomanolakisA P Efremidis
Oct 25, 2003·Oncogene·Zahid H Siddik
Jan 27, 2004·Advanced Drug Delivery Reviews·G M SteilK Rebrin
Apr 20, 2004·Anti-cancer Drugs·Ornella GarroneMarco Merlano
Apr 28, 2004·Breast Cancer Research and Treatment·Yong CuiWei Zheng
Jun 5, 2004·The Breast : Official Journal of the European Society of Mastology·D A VorobiofC Mohammed
Oct 19, 2004·Nutrition and Cancer·Jiahua JiangDaniel Sliva
Jul 9, 2005·Clinical Breast Cancer·Joyce A O'ShaughnessyDenise A Yardley
Jul 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezGabriel N Hortobagyi
Jan 6, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mia M GaudetSusan M Gapstur
Citations
Dec 2, 2015·Oncology Letters·Lin YeWen G Jiang
Oct 20, 2009·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Chong-Zhi WangChun-Su Yuan
Aug 21, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Shu-Yi YinNing-Sun Yang
Jul 10, 2014·BMC Complementary and Alternative Medicine·Ying LiuShi Liu
Dec 1, 2009·The Veterinary Journal·Wei LiuWu-Chun Cao
Dec 1, 2011·Food Chemistry·Hui DuSicen Wang
May 11, 2011·Toxicology Letters·Anna StachurskaAgnieszka Loboda
Feb 18, 2009·The American Journal of Chinese Medicine·Hyo Jeong LeeJunxuan Lü
Dec 17, 2015·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Gang ChenShi-Ying Yu
Aug 10, 2020·Medicine·Daorui HouLu Xiong
Aug 9, 2019·Medicine·Jianling LiuWei Ding
Oct 27, 2020·Frontiers in Pharmacology·Ting FangDan-Dan Zhang